Item 1(a). | Name of Issuer: |
Provention Bio, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
P.O. Box 666, Oldwick, New Jersey, New Jersey 08858
Item 2(a). | Names of Persons Filing: |
The names of the persons filing this report (collectively, the “Reporting Persons”) are:
Perceptive Advisors LLC (“Perceptive Advisors”)
Joseph Edelman (“Mr. Edelman”)
Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 per share (“Common Stock”)
74374N 102
Item 3. | If this statement is filed pursuant to§§240.13d-1(b) or240.13d-2(b) or (c), checkwhether the person filing is a: |
Not applicable.
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 47,638,361 shares of Common Stock outstanding as reported in the Issuer’sForm 10-Q filed on November 5, 2019.
The Master Fund directly holds 2,921,574 shares of Common Stock. Perceptive Advisors serves as the investment manager to the funds and may be deemed to beneficially own the securities directly held by the funds. Mr. Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the securities directly held by the funds.